Topic Highlight
Copyright ©The Author(s) 2016.
World J Gastroenterol. Jan 7, 2016; 22(1): 300-325
Published online Jan 7, 2016. doi: 10.3748/wjg.v22.i1.300
Table 1 Hepatitis B virus-related transgenic mice
TransgenePromoterExpressionPathologyRef.
PreS/S/XEndogenousSurface proteinsUntil 6 mo: no obvious pathology[28]
PreS/S/X (two TGs)Endogenous and mouse metallothionein ISurface proteinsNot determined[29]
PreS/S/XMouse metallothionein I and AlbuminSurface proteinsGround glass[22,30-32,34]
7-9 mo: adenoma
12 mo: HCC
18 mo: HCC (100%)
Genome (2X)EndogenousSurface proteinsNot determined[241]
PreS/S (Knock-in)Mouse p21Surface proteins15-24 mo: HCC [53% (♂KI/+), 72% (♂KI/KI), 0% (♀KI/+ and KI/KI)][37]
PreS/SEndogenousSurface proteinsHCC[33,40]
XHuman α-1-antitrypsinHBx proteinFocal necrosis, hyperplasia nodule (Authors claimed that X is not tumorigenic)[42]
XEndogenousHBx protein4 mo: altered hepatocyte in multifocal area[43,44]
10 mo: tumor nodule
16 mo: tumor (80%)
24 mo: HCC (84%)
XEndogenousHBx protein6 mo: neoplastic nodules (66.6%)[41]
15-18 mo: small neoplastic nodule (100%) and HCC (75%)
X (Knock-in)Mouse p21HBx protein15-24 mo: HCC [60%-64% (♂KI/+ and KI/KI), 43%-46% (♀KI/+ and KI/KI)][37]
XMouse albuminHBx protein12 mo: dysplasia nodule (100%)[45-47]
16 mo: HCC (80%)
20 mo: HCC (90%-100%)
Precore/coreMouse metallothionein IPrecore proteinNot determined[56]
Precore/coreEndogenousCore protein12 mo: no hepatitis or HCC[13,57]
Precore/core (two TGs)EndogenousPrecore and core proteinsNot determined[58]
Genome (2X)EndogenousReplicative intermediates10 mo: no obvious pathology[60]
Genome (1.2X)EndogenousReplicative virus12 mo: no hepatitis or HCC[59,61]
24 mo: no obvious pathology
Genome (1.3X)EndogenousReplicative intermediatesUntil 12 mo: no obvious pathology[62]